AI for MRI 市场 - 全球产业规模、份额、趋势、机会及预测（按临床应用、产品类型、技术、部署类型、最终用途、地区和竞争格局划分，2021-2031 年）

全球用于 MRI 的 AI 市场预计将从 2025 年的 17.3 亿美元成长到 2031 年的 45.8 亿美元，复合年增长率为 17.62%。

该领域涉及将机器学习和深度学习技术整合到磁振造影(MRI) 工作流程中，以实现影像重建的自动化并辅助诊断解读。推动这项发展的关键因素包括：迫切需要缩短扫描时间以提高患者就诊效率，以及由于病例数量不断增加而需要减轻放射科医师的工作量。欧洲放射学会 (ESR) 2024 年的数据显示，48% 的受访会员表示目前在其临床实践中使用人工智慧工具，这印证了这项技术变革。

然而，市场成长的一大障碍是实施所需的大量资本投入。取得软体授权和升级IT基础设施的高成本构成了一道重要的进入门槛，尤其对于发展中地区的中小型独立诊所和医疗系统而言更是如此。因此，儘管这些工具能够显着提高营运效率，但预算限制往往迫使医疗机构推迟采用。

市场驱动因素

放射科医师严重短缺和诊断影像工作量的快速成长是推动人工智慧在磁振造影（MRI）领域应用的关键因素。医疗系统面临诊断扫描需求与解读所需人才之间日益扩大的差距，因此亟需自动化解决方案来防止医护人员过度劳累和延迟诊断。劳动力数据也印证了这种不平衡。根据英国皇家放射学院于2024年6月发布的《2023年临床放射科劳动力调查报告》，英国英国放射科医生人数在2023年将增长6%，但对CT和MRI阅片的需求将增长11%，这将给现有医护人员带来更大的压力。

此外，深度学习技术的进步增强了影像重建能力，直接提高了营运效率和患者吞吐量，从而推动了市场扩张。现代人工智慧演算法能够从欠采样原始资料中产生高解析度影像，显着缩短患者在扫描仪中的停留时间，同时又不影响诊断品质。 2024年12月，GE医疗发布了「Sonic DL for 3D」深度学习技术，将MRI扫描时间缩短了高达86%，充分展现了这项能力。这种效率提升潜力吸引了大量资金，Ezra公司于2024年2月成功资金筹措2,100万美元，以加速其人工智慧驱动的MRI服务的扩张。

市场挑战

实施所需的大量资本投入极大地限制了全球人工智慧在磁振造影（MRI）领域的市场成长。部署这些解决方案涉及高昂的软体授权费用和IT基础设施升级成本，以适应资料密集型工作流程。这些财务要求构成了巨大的进入门槛，尤其对于预算有限的小规模独立诊所和发展中地区的医疗系统而言更是如此。因此，儘管这些技术具有提升营运效率的潜力，但医疗机构往往会延后采用，阻碍了市场充分发挥其潜力。

近期统计数据印证了这些经济限制对产业的影响。根据欧洲放射学会 (ESR) 2024 年的数据，49.5% 的受访会员表示，成本或预算不足是其临床环境中采用人工智慧的主要障碍。这表明，资金障碍是放射科迟迟不愿整合这些工具的主要原因。如果没有足够的资金来支付初始成本，相当一部分市场将无法利用人工智慧技术，这将直接限制整个市场的扩张。

市场趋势

将生成式人工智慧 (AI) 整合到放射学报告中正迅速普及，成为解决诊断工作流程中繁重行政负担的关键方案。这一趋势超越了传统的影像分析，利用大规模语言模型，根据影像学观察和放射科医生的口述自动创建、自订和建立临床报告，从而减少文件记录时间和放射科医生的疲劳。 2025 年 1 月，Rad AI 完成 6,000 万美元的 C 轮资金筹措，加速其生成式 AI 报告平台在大型医疗系统中的应用，这有力地证明了该技术的商业性可行性。

同时，厂商中立的AI应用商店的兴起正在改变医疗机构部署和运作人工智慧工具的方式。医院不再需要管理与各个开发商签订的零散合同，而是越来越多地采用整合平台，以便集中管理来自多个供应商的各种演算法。这项整合策略在2025年12月举行的RSNA 2025大会上得到了重点展示。当时，DeepHealth发布了AI Studio，编配平台，整合了来自75多家供应商的140多种AI演算法，并简化了临床部署和管治。

目录

第一章概述

第二章调查方法

第三章执行摘要

第四章：客户评价

第五章 全球MRI人工智慧市场展望

• 市场规模及预测
  • 按金额
• 市占率及预测
  • 依临床应用（肌肉骨骼、结肠、前列腺、肝臟、心血管、神经系统、肺部、乳房、其他）
  • 依供应类型（硬体、软体、服务）
  • 按技术（深度学习、机器学习、电脑视觉、自然语言处理、语音辨识、查询方法等）
  • 依部署类型（本机部署、云端部署）
  • 依最终使用者（医院、诊所、实验室等）划分
  • 按地区
  • 按公司（2025 年）
• 市场地图

第六章 北美MRI人工智慧市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 我们
  • 加拿大
  • 墨西哥

第七章 欧洲人工智慧在磁振造影市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

8. 亚太地区MRI人工智慧市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

9. 中东和非洲MRI人工智慧市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非

第十章：南美MRI人工智慧市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章 市场动态

• 司机
• 任务

第十二章 市场趋势与发展

• 併购
• 产品发布
• 最新进展

第十三章 全球人工智慧在磁振造影市场的应用：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的可能性
• 供应商电力
• 顾客权力
• 替代品的威胁

第十五章 竞争格局

• Digital Diagnostics Inc.
• Tempus AI, Inc.
• Advanced Micro Devices, Inc.
• HeartFlow, Inc.
• Enlitic, Inc.
• Viz.ai, Inc.
• EchoNous Inc.
• HeartVista Inc.
• Exo Imaging, Inc.
• Nano-X Imaging Ltd.

第十六章 策略建议

第十七章：关于研究公司及免责声明

The Global AI in MRI Market is projected to expand from USD 1.73 Billion in 2025 to USD 4.58 Billion by 2031, registering a CAGR of 17.62%. This sector encompasses machine learning and deep learning technologies integrated into magnetic resonance imaging workflows to automate image reconstruction and support diagnostic interpretation. Key drivers for this growth include the urgent need to shorten scan times for better patient throughput and the demand to alleviate radiologist burnout amidst rising caseloads. Evidence of this technological shift is found in recent data from the European Society of Radiology, which reported in 2024 that 48% of its surveyed members are currently utilizing AI tools in their clinical practice.

However, a major obstacle hindering market growth is the substantial capital investment needed for deployment. The high costs involved in acquiring software licenses and upgrading IT infrastructure present a significant barrier to entry, particularly for smaller independent clinics and healthcare systems in developing regions. As a result, budgetary limitations frequently compel facilities to postpone the implementation of these tools, despite the operational efficiencies they promise.

Market Driver

A critical shortage of radiologists alongside surging imaging workloads is a primary force driving the adoption of AI in MRI. Healthcare systems are contending with a growing gap between the volume of necessary diagnostic scans and the workforce available to interpret them, necessitating automated solutions to prevent burnout and delays in diagnosis. This imbalance is underscored by workforce data; according to the Royal College of Radiologists' '2023 Clinical Radiology Workforce Census Report' released in June 2024, while the UK clinical radiology workforce increased by 6% in 2023, the demand for CT and MRI reporting rose by 11%, intensifying pressure on existing staff.

Additionally, advancements in deep learning for enhanced image reconstruction are fueling market expansion by directly improving operational efficiency and patient throughput. Modern AI algorithms allow for the creation of high-fidelity images from undersampled raw data, drastically reducing the time patients spend in scanners without sacrificing diagnostic quality. This capability was highlighted in December 2024 when GE HealthCare introduced Sonic DL for 3D, a deep learning innovation that reduces MRI scan times by up to 86%. The potential for such efficiency has attracted significant capital, as seen in February 2024 when Ezra secured $21 million to accelerate the expansion of its AI-powered MRI services.

Market Challenge

The substantial capital investment necessary for deployment significantly restricts the growth of the Global AI in MRI Market. Implementing these solutions entails high costs related to purchasing software licenses and upgrading IT infrastructure to handle data-intensive workflows. These financial requirements establish a formidable barrier to entry, particularly for smaller independent clinics and healthcare systems in developing regions that operate with limited budgets. Consequently, facilities frequently delay adoption despite the potential for enhanced operational efficiency, preventing the market from achieving its full potential volume.

Recent statistics reinforce the impact of these economic constraints on the sector. Data from the European Society of Radiology in 2024 revealed that 49.5% of surveyed members cited costs or a lack of budget as the primary barrier to implementing AI in clinical practice. This suggests that financial hurdles are a leading reason for the hesitation among radiology departments to integrate these tools. Without the necessary funding to cover initial expenses, a significant portion of the market remains unable to leverage AI capabilities, thereby directly limiting overall market expansion.

Market Trends

The integration of Generative AI for Radiology Reporting is fast becoming a crucial solution to the administrative burdens straining diagnostic workflows. Moving beyond standard image analysis, this trend employs large language models to automatically draft, customize, and structure radiological reports based on image findings and radiologist dictation, thereby cutting down documentation time and reducing radiologist fatigue. The commercial viability of this technology was strongly confirmed in January 2025, when Rad AI raised $60 million in Series C funding to hasten the adoption of its generative AI reporting platform across major healthcare systems.

Concurrently, the rise of Vendor-Neutral AI App Stores is transforming how healthcare facilities acquire and deploy artificial intelligence tools. Instead of managing fragmented contracts with individual developers, hospitals are increasingly adopting centralized orchestration platforms that offer a single interface for managing diverse algorithms from multiple vendors. This consolidation strategy was emphasized in December 2025 at RSNA 2025, where DeepHealth unveiled AI Studio, an orchestration platform integrating over 140 AI algorithms from more than 75 vendors to streamline clinical deployment and governance.

Key Market Players

• Digital Diagnostics Inc.
• Tempus AI, Inc.
• Advanced Micro Devices, Inc.
• HeartFlow, Inc.
• Enlitic, Inc.
• Viz.ai, Inc.
• EchoNous Inc.
• HeartVista Inc.
• Exo Imaging, Inc.
• Nano-X Imaging Ltd.

Report Scope

In this report, the Global AI in MRI Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

AI in MRI Market, By Clinical Application

• Musculoskeletal
• Colon
• Prostate
• Liver
• Cardiovascular
• Neurology
• Lung
• Breast
• Others

AI in MRI Market, By Offering Type

• Hardware
• Software
• Services

AI in MRI Market, By Technology

• Deep Learning
• Machine Learning
• Computer Vision
• NLP
• Speech Recognition
• Querying Method
• Others

AI in MRI Market, By Deployment Type

• On-premises
• Cloud

AI in MRI Market, By End Use

• Hospitals
• Clinics
• Research & Laboratories
• Others

AI in MRI Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global AI in MRI Market.

Available Customizations:

Global AI in MRI Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global AI in MRI Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Clinical Application (Musculoskeletal, Colon, Prostate, Liver, Cardiovascular, Neurology, Lung, Breast, Others)
  • 5.2.2. By Offering Type (Hardware, Software, Services)
  • 5.2.3. By Technology (Deep Learning, Machine Learning, Computer Vision, NLP, Speech Recognition, Querying Method, Others)
  • 5.2.4. By Deployment Type (On-premises, Cloud)
  • 5.2.5. By End Use (Hospitals, Clinics, Research & Laboratories, Others)
  • 5.2.6. By Region
  • 5.2.7. By Company (2025)
• 5.3. Market Map

6. North America AI in MRI Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Clinical Application
  • 6.2.2. By Offering Type
  • 6.2.3. By Technology
  • 6.2.4. By Deployment Type
  • 6.2.5. By End Use
  • 6.2.6. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States AI in MRI Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Clinical Application
      • 6.3.1.2.2. By Offering Type
      • 6.3.1.2.3. By Technology
      • 6.3.1.2.4. By Deployment Type
      • 6.3.1.2.5. By End Use
  • 6.3.2. Canada AI in MRI Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Clinical Application
      • 6.3.2.2.2. By Offering Type
      • 6.3.2.2.3. By Technology
      • 6.3.2.2.4. By Deployment Type
      • 6.3.2.2.5. By End Use
  • 6.3.3. Mexico AI in MRI Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Clinical Application
      • 6.3.3.2.2. By Offering Type
      • 6.3.3.2.3. By Technology
      • 6.3.3.2.4. By Deployment Type
      • 6.3.3.2.5. By End Use

7. Europe AI in MRI Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Clinical Application
  • 7.2.2. By Offering Type
  • 7.2.3. By Technology
  • 7.2.4. By Deployment Type
  • 7.2.5. By End Use
  • 7.2.6. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany AI in MRI Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Clinical Application
      • 7.3.1.2.2. By Offering Type
      • 7.3.1.2.3. By Technology
      • 7.3.1.2.4. By Deployment Type
      • 7.3.1.2.5. By End Use
  • 7.3.2. France AI in MRI Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Clinical Application
      • 7.3.2.2.2. By Offering Type
      • 7.3.2.2.3. By Technology
      • 7.3.2.2.4. By Deployment Type
      • 7.3.2.2.5. By End Use
  • 7.3.3. United Kingdom AI in MRI Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Clinical Application
      • 7.3.3.2.2. By Offering Type
      • 7.3.3.2.3. By Technology
      • 7.3.3.2.4. By Deployment Type
      • 7.3.3.2.5. By End Use
  • 7.3.4. Italy AI in MRI Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Clinical Application
      • 7.3.4.2.2. By Offering Type
      • 7.3.4.2.3. By Technology
      • 7.3.4.2.4. By Deployment Type
      • 7.3.4.2.5. By End Use
  • 7.3.5. Spain AI in MRI Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Clinical Application
      • 7.3.5.2.2. By Offering Type
      • 7.3.5.2.3. By Technology
      • 7.3.5.2.4. By Deployment Type
      • 7.3.5.2.5. By End Use

8. Asia Pacific AI in MRI Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Clinical Application
  • 8.2.2. By Offering Type
  • 8.2.3. By Technology
  • 8.2.4. By Deployment Type
  • 8.2.5. By End Use
  • 8.2.6. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China AI in MRI Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Clinical Application
      • 8.3.1.2.2. By Offering Type
      • 8.3.1.2.3. By Technology
      • 8.3.1.2.4. By Deployment Type
      • 8.3.1.2.5. By End Use
  • 8.3.2. India AI in MRI Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Clinical Application
      • 8.3.2.2.2. By Offering Type
      • 8.3.2.2.3. By Technology
      • 8.3.2.2.4. By Deployment Type
      • 8.3.2.2.5. By End Use
  • 8.3.3. Japan AI in MRI Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Clinical Application
      • 8.3.3.2.2. By Offering Type
      • 8.3.3.2.3. By Technology
      • 8.3.3.2.4. By Deployment Type
      • 8.3.3.2.5. By End Use
  • 8.3.4. South Korea AI in MRI Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Clinical Application
      • 8.3.4.2.2. By Offering Type
      • 8.3.4.2.3. By Technology
      • 8.3.4.2.4. By Deployment Type
      • 8.3.4.2.5. By End Use
  • 8.3.5. Australia AI in MRI Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Clinical Application
      • 8.3.5.2.2. By Offering Type
      • 8.3.5.2.3. By Technology
      • 8.3.5.2.4. By Deployment Type
      • 8.3.5.2.5. By End Use

9. Middle East & Africa AI in MRI Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Clinical Application
  • 9.2.2. By Offering Type
  • 9.2.3. By Technology
  • 9.2.4. By Deployment Type
  • 9.2.5. By End Use
  • 9.2.6. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia AI in MRI Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Clinical Application
      • 9.3.1.2.2. By Offering Type
      • 9.3.1.2.3. By Technology
      • 9.3.1.2.4. By Deployment Type
      • 9.3.1.2.5. By End Use
  • 9.3.2. UAE AI in MRI Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Clinical Application
      • 9.3.2.2.2. By Offering Type
      • 9.3.2.2.3. By Technology
      • 9.3.2.2.4. By Deployment Type
      • 9.3.2.2.5. By End Use
  • 9.3.3. South Africa AI in MRI Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Clinical Application
      • 9.3.3.2.2. By Offering Type
      • 9.3.3.2.3. By Technology
      • 9.3.3.2.4. By Deployment Type
      • 9.3.3.2.5. By End Use

10. South America AI in MRI Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Clinical Application
  • 10.2.2. By Offering Type
  • 10.2.3. By Technology
  • 10.2.4. By Deployment Type
  • 10.2.5. By End Use
  • 10.2.6. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil AI in MRI Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Clinical Application
      • 10.3.1.2.2. By Offering Type
      • 10.3.1.2.3. By Technology
      • 10.3.1.2.4. By Deployment Type
      • 10.3.1.2.5. By End Use
  • 10.3.2. Colombia AI in MRI Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Clinical Application
      • 10.3.2.2.2. By Offering Type
      • 10.3.2.2.3. By Technology
      • 10.3.2.2.4. By Deployment Type
      • 10.3.2.2.5. By End Use
  • 10.3.3. Argentina AI in MRI Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Clinical Application
      • 10.3.3.2.2. By Offering Type
      • 10.3.3.2.3. By Technology
      • 10.3.3.2.4. By Deployment Type
      • 10.3.3.2.5. By End Use

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global AI in MRI Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Digital Diagnostics Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Tempus AI, Inc.
• 15.3. Advanced Micro Devices, Inc.
• 15.4. HeartFlow, Inc.
• 15.5. Enlitic, Inc.
• 15.6. Viz.ai, Inc.
• 15.7. EchoNous Inc.
• 15.8. HeartVista Inc.
• 15.9. Exo Imaging, Inc.
• 15.10. Nano-X Imaging Ltd.

16. Strategic Recommendations

17. About Us & Disclaimer